These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 37370069)

  • 1. Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trial.
    Witztum JL; Gaudet D; Arca M; Jones A; Soran H; Gouni-Berthold I; Stroes ESG; Alexander VJ; Jones R; Watts L; Xia S; Tsimikas S
    J Clin Lipidol; 2023; 17(3):342-355. PubMed ID: 37100699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical profile, genetic spectrum and therapy evaluation of 19 Chinese pediatric patients with lipoprotein lipase deficiency.
    Xia Y; Zheng W; Du T; Gong Z; Liang L; Wang R; Yang Y; Zhang K; Lu D; Chen X; Sun Y; Sun Y; Xiao B; Qiu W
    J Clin Lipidol; 2023; 17(6):808-817. PubMed ID: 37858495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of volanesorsen on triglycerides and pancreatitis in patients with familial chylomicronaemia syndrome (FCS) in the UK Early Access to Medicines Scheme (EAMS).
    Jones A; Peers K; Wierzbicki AS; Ramachandran R; Mansfield M; Dawson C; Ochoa-Ferraro A; Soran H; Jenkinson F; McDowell I; Downie P; Hamilton P; Jones RD
    Atherosclerosis; 2023 Jun; 375():67-74. PubMed ID: 37253281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Symptoms and impacts of familial chylomicronemia syndrome: a qualitative study of the patient experience.
    Williams K; Tickler G; Valdivielso P; Alonso J; Vera-Llonch M; Cubells L; Acaster S
    Orphanet J Rare Dis; 2023 Oct; 18(1):316. PubMed ID: 37817256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two successful pregnancies -in patients taking Volanesorsen for familial chylomicronemia syndrome.
    Wanninayake S; Ochoa-Ferraro A; Patel K; Ramachandran R; Wierzbicki AS; Dawson C
    JIMD Rep; 2024 Jul; 65(4):249-254. PubMed ID: 38974616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-Alcoholic Fatty Liver in Patients with Chylomicronemia.
    Maltais M; Brisson D; Gaudet D
    J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33572376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qualitative development of the PROMIS Profile v1.0-Familial Chylomicronemia Syndrome (FCS) 28.
    Kaiser K; Fox RS; Perschon C; Vera-Llonch M; Alonso J; Cubells L; Cella D
    Qual Life Res; 2023 Feb; 32(2):605-614. PubMed ID: 36310187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein C-III, familial chylomicronemia syndrome, and olezarsen.
    Valdivielso P; Coca Prieto I
    Med; 2024 Jun; 5(6):493-494. PubMed ID: 38878767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertriglyceridaemia due to genetic defects in lipoprotein lipase and apolipoprotein C-II.
    Fojo SS; Brewer HB
    J Intern Med; 1992 Jun; 231(6):669-77. PubMed ID: 1619390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Therapy for Hypertriglyceridemia and Familial Chylomicronemia Syndrome: Focus on Volnesorsen.
    Gesner M; Frishman WH
    Cardiol Rev; 2023 Nov-Dec 01; 31(6):325-329. PubMed ID: 36129324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying suspected familial chylomicronemia syndrome.
    Rengarajan R; McCullough PA; Chowdhury A; Tecson KM
    Proc (Bayl Univ Med Cent); 2018 Jul; 31(3):284-288. PubMed ID: 29904289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six-year follow-up of a child with familial chylomicronemia syndrome: disease course and effectiveness of gemfibrozil treatment --case report and literature review.
    Mustafa M; Almheiri M
    Ann Pediatr Endocrinol Metab; 2024 Apr; 29(2):130-134. PubMed ID: 38224692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characterization and mutation spectrum of patients with hypertriglyceridemia in a German outpatient clinic.
    Bardey F; Rieck L; Spira D; März W; Binner P; Schwab S; Kleber ME; Danyel M; Barkowski R; Bobbert T; Spranger J; Steinhagen-Thiessen E; Demuth I; Kassner U
    J Lipid Res; 2024 Jul; ():100589. PubMed ID: 38969064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of the familial chylomicronaemia syndrome (FCS) score in an ethnically diverse cohort from UK FCS registry: Implications for diagnosis and differentiation from multifactorial chylomicronaemia syndrome (MCS).
    Bashir B; Kwok S; Wierzbicki AS; Jones A; Dawson C; Downie P; Jenkinson F; Delaney H; Mansfield M; Datta D; Teoh Y; Hamilton P; Forrester N; O'Sullivan D; Ferdousi M; Durrington PN; AbdelRazik A; Gallo A; Moulin P; Soran H
    Atherosclerosis; 2024 Apr; 391():117476. PubMed ID: 38447437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corrigendum to "Volanesorsen and triglyceride levels in familial chylomicronemia syndrome: Long-term efficacy and safety data from patients in an open-label extension trial" [Journal of Clinical Lipidology, Volume 17, Issue 3, May-June 2023, Pages 342-355].
    Witztum JL; Gaudet D; Arca M; Jones A; Soran H; Gouni-Berthold I; Stroes ESG; Alexander VJ; Jones R; Watts L; Xia S; Tsimikas S
    J Clin Lipidol; 2024; 18(3):e482-e483. PubMed ID: 38565460
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of Angiopoietin-Like Protein 3 or 3/8 Complex and ApoC-III in Severe Hypertriglyceridemia.
    Larouche M; Khoury E; Brisson D; Gaudet D
    Curr Atheroscler Rep; 2023 Dec; 25(12):1101-1111. PubMed ID: 38095804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-prandial analysis of fluctuations in the platelet count and platelet function in patients with the familial chylomicronemia syndrome.
    Larouche M; Brisson D; Morissette MC; Gaudet D
    Orphanet J Rare Dis; 2023 Jun; 18(1):167. PubMed ID: 37370069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and biochemical features of different molecular etiologies of familial chylomicronemia.
    Hegele RA; Berberich AJ; Ban MR; Wang J; Digenio A; Alexander VJ; D'Erasmo L; Arca M; Jones A; Bruckert E; Stroes ES; Bergeron J; Civeira F; Witztum JL; Gaudet D
    J Clin Lipidol; 2018; 12(4):920-927.e4. PubMed ID: 29748148
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.